Prostate Cancer: A Comprehensive Perspective (eBook)

 ContentsForewordList of Contributors  Section 1: Basic Scientific FoundationEditors: John D. Kelly, Hardev Pandha, Maria Shevchuk, Karl-Dietrich Sievert, and Atsushi Takenaka 1. Development, Applied and Surgical Anatomy of the ProstateAnthony J. Costello and Niall M. Corcoran 2. Molecular Biology and Prostate CancerGreg L. Shaw and David E. Neal 3. Endocrine Mechanisms, Androgen Receptor and Carcinogenesis, Hormone EscapeKaustubh Datta and Donald Tindall 4. Molecular Mechanisms of Castrate Resistant Prostate CancerFrancois Lamoureux, Amina Zoubeidi, and Martin E. Gleave 5. Immunologic Aspects of Prostate Cancer Christine Galustian, Oussama Elhage, Richard Smith, and Prokar Dasgupta 6. Stem Cells in Carcinogenesis of the ProstateShi-Ming Tu and Sue-Hwa Lin 7. Murine Models of Prostate CancerEric C. Kauffman, Casey K. Ng, and Carrie Rinker-Schaeffer 8. Prostate Cancer and the Metabolic SyndromeStephen EM Langley and Jenny P. Nobes 9. Inflammation and Cancer of the ProstateSonya Vasto, Emilio Italiano, Vitale Miceli, and Giuseppe Carruba 10. HIV and Prostate Cancer Matthew S. Wosnitzer, Jennifer J. Ahn, and Franklin C. Lowe 11. Prostate Cancer GeneticsSashi S. Kommu, Samuel Bishara, and Stephen M. Edwards 12. Gene Expression Profiling and Somatic Genome ChangesMichael Ittmann 13. The Proteomic Approach to Prostate CancerSashi S. Kommu and Emanual Petricoin 14. Epigenetic Changes in Prostate CancerWilliam G. Nelson, Michael C. Haffner, Angelo M. De Marzo, and Srinivasan Yegnasubramanian 15. Biomarkers of Potential Therapeutic ValueHideaki Miyake, Atsushi Takenaka, and Masato Fujisawa 16. Prostate Tissue BankingHarveer Dev, Prasanna Sooriakumaran, and Ashutosh Tewari 17. Molecular Imaging in DiagnosticsCasey Ng, Eric Kauffman, and Hossein Jadvar 18. Molecular Risk ProfilingNeil E. Martin 19. Premalignant Lesions of the ProstateDaniel M. Berney and Anne Y. Warren 20. The Pathology of Prostatic CarcinomaMaria Shevchuk and Brian D. Robinson 21. The Pathology of Non-Epithelial Tumors of the ProstateMaria Shevchuk and Brian D. Robinson 22. Neuroendocrine Prostate CancerHimisha Beltran, Juan Miguel Mosquera, and Mark A. Rubin Section 2: Epidemiology, Screening, and ChemopreventionEditors: Neil Fleshner, Cynthia Kuk, William Nelson, and Alexandre Zlotta 23. Epidemiology of Prostate CancerAnkur M. Manvar, Raj S. Pruthi, Eric. M. Wallen, and Matthew E. Nielsen 24. Racial Disparities and the Global PictureJames E. Ferguson III, Matthew Nielsen, Eric Wallen, Raj Pruthi 25. Natural History of Prostate CancerPaul K. Hegarty and Nicholas J. Hegarty 26. Population-Based Health Systems as a Foundation for Prostate Cancer Control Research: The Cancer Research NetworkMark C. Hornbrook and Joan Holup 27. Screening for Prostate CancerDavid R. Yates and John B. Anderson 28. Next Generation Screening TestsJack A. Schalken and Rizal Hamid 29. Diet and Prostate Cancer: A Holistic Approach to ManagementPhilippa J. Cheetham and Aaron E. Katz 30. Estrogens in Prostate CancerGiuseppe Carruba 31. Vitamin D and Prostate CancerNaomi Smith and Alejandro Nolazco 32. The Role of 5a-Reductase Inhibitors (5-ARIs) in Prostate Cancer ChemopreventionDavid Margel and Neil Fleshner 33. Other Pharmaceutical Agents in the Chemoprevention of Prostate CancerVivekanandan Kumar Section 3: Diagnosis and StagingEditors: Peter Carroll and Gary Dorfman 34. Early-Detection and Patient Risk Stratification in Prostate CancerRajesh Nair, John Withington, Sukanya Ghosh, and Alastair Henderson 35. Tumor MarkersDiederick Duijvesz and Guido Jenster 36. Prostate Specific Membrane Antigen-Based DiagnosticsJoseph Osborne, Scott T. Tagawa, Shankar Vallabhajosula, Stanley J. Goldsmith, and Neil H. Bander 37. Prostate Specific Membrane Antigen-Based TherapeuticsScott T. Tagawa, Joseph Osborne, Shankar Vallabhajosula, Stanley J. Goldsmith, and Neil H. Bander 38. Presentation and Symptomatology of Prostate CancerAgnieszka Michael and Hardev Pandha 39. The Role of UltrasonographySuzanne van den Heuvel, Paul C.M.S. Verhagen, and Chris H. Bangma 40. The Use of Magnetic Resonance Imaging in the Management of Prostate CancerMatthieu Durand, Aude Fregeville, Naveen Gumpeni, Abhishek Srivastava, Prasanna Sooriakumaran, Siobhan Gruschow, Niyati Harneja, Kristin M. Saunders, Jean Amiel, and Ashutosh K. Tewari 41. The Role of Functional Magnetic Resonance Imaging TechniquesPieter J. De Visschere, Gert O. De Meerleer, Nicolaas Lumen, and Geert M. Villeirs 42. Prostate BiopsyParas B. Singh, Caroline M. Moore, and Mark Emberton 43. The Staging of Prostate CancerBenjamin J. Challacombe and Giles Rottenberg 44. Nuclear Medicine in Prostate CancerVinayaka Moorthy Majuran, Vidhiya Vinayakamoorthy, and Derek Svasti-Salee 45. Nanotechnology and Prostate CancerSashi S. Kommu, Lidong Qin, Louis Brousseau, Amrith Rao, Philippe Grange, and Mauro Ferrari Section 4: Risk Assessment and Decision-Making Strategies for Localized Prostate CancerEditor: Matthew Cooperberg 46. Disease Risk StratificationAlistair Henderson 47. Nomograms in Prostate CancerCarvell T. Nguyen and Michael W. Kattan 48. Comparative Effectiveness of Treatment Alternatives for Localized Prostate CancerMatthew R. Cooperberg Section 5: Management of Localized DiseaseEditors: Prokar Dasgupta, Alex Mottrie, Abhay Rane, Joseph Smith, Datta Wagle, and Peter Wiklund 49. Radical Treatment for Localized Disease: An Overview of Options and Strategies for Decision MakingJoseph A. Smith, Jr. 50. Quality of Life and Management of Localized DiseaseAndreas E. Nilsson, Gunnar Steineck, and N. Peter Wiklund 51. Active Surveillance for Favorable-Risk Prostate CancerNathan Lawrentschuk and Laurence Klotz 52. Anesthesia for Robotic-Assisted ProstatectomyVinod Malhotra and Peter M. Fleischut 53. Retropubic Radical Prostatectomy: The TechniqueHein Van Poppel and Steven Joniau 54. Retropubic Radical Prostatectomy: The ResultsWolfgang Horninger and Jasmine Bektic 55. Radical Perineal ProstatectomyRolf Gillitzer and Joachim W. Thüroff 56. Laparoscopic Radical Prostatectomy: The TechniqueChristopher Eden and Anthony Hutton 57. Laparoscopic Radical Prostatectomy: The ResultsEvangelos Liatsikos, Odysseas Andrikopoulos, Panagiotis Kallidonis, and Jens-Uwe Stolzenburg 58. Robotic Assisted Radical Prostatectomy: The TechniqueSameer Chopra, Abhishek Srivastava, Prasanna Sooriakumaran, and Ashutosh K. Tewari 59. Lymph Node Dissection in Prostate Cancer SurgeryAaron Bernie, Douglas S. Scherr, and Michael P. Herman 60. External Beam Radiotherapy for Low Risk Prostate CancerGert De Meerleer, Piet Ost, Geert Villeirs, Nicolaas Lumen, and Valérie Fonteyne 61. Prostate Brachytherapy: Low Dose RatePeter Grimm 62. Prostate Brachytherapy: High Dose RateCarl Salembier and Peter Hoskin 63. Intensity Modulated RadiotherapyBridget F. Koontz, Devon Godfrey, and W. Robert Lee 64. Proton Beam Therapy and Novel Radiotherapeutic Approaches to the Treatment of Prostate CancerJeffrey J. Meyer, Jordan A. Holmes, and Ronald C. Chen 65. Prostate CryotherapyMohamed Ismail, Shwan Ahmed, and John Davies 66. Focal Therapies for Localized Prostate CancerLouise Dickinson, Hashim U. Ahmed, and Mark Emberton Section 6: Failure and Management of Recurrent, Locally Advanced, and Advanced DiseaseEditors: Andrew Armstrong, Ronald Chen, Richard Stock, and John Sylvester 67. Biochemical Failure in Prostate CancerTian Zhang and Andrew Z. Wang 68. The Phenomenon of PSA Bounce After Radiation TherapyPeter Acher and Rick Popert 69. Management of Locally Recurrent DiseasePiet Ost, Valérie Fonteyne, Pieter De Visschere, Nicolaas Lumen, and Gert De Merleer 70. Management of High Risk/Locally Advanced DiseaseValérie Fonteyne, Piet Ost, Nicolaas Lumen, Geert Villeirs, and Gert De Meerleer 71. Radiotherapy Plus Hormonal TherapyJordan A. Holmes and Ronald Chen 72. Watchful Waiting in Advanced Prostate CancerMaria Carmen Mir and Nathan Lawrentschuk 73. Androgen and Androgen Receptor Directed Therapy as Initial Treatment for Prostate CancerBruce Montgomery and Peter S. Nelson 74. Hormone-Based Therapies for Castration Resistant Prostate CancerElahe A. Mostaghel and Peter S. Nelson 75. Toxicity of Androgen Deprivation Therapy in Hormone Sensitive Prostate CancerNaveed H. Akhtar, Elan S. Diamond, Nicole Eiseler, and Scott T. Tagawa 76. Chemotherapy and Novel Systemic Approaches in the Treatment of Metastatic Castration Resistant Prostate CancerRobyn J. Macfarlane, Chris Hovens, Niall M. Corcoran, and Kim N. Chi 77. ImmunotherapyNicola E. Annels and Hardev Pandha 78. Bone Health: Prevention of Skeletal Related Events and Palliative CareJean-Baptiste Lattouf and Fred Saad Section 7: Outcomes and Complications After TreatmentEditors: Mark Emberton, Brent Hollenbeck, and Tom Lue 79. Assessment of Treatment Outcomes Following Prostate Cancer TherapyPaul Cathcart and Mark Emberton 80. Urinary IncontinenceTed A. Skolarus 81. Erectile DysfunctionMaarten Albersen and Tom F. Lue 82. Immediate/Early Surgical ComplicationsThomas J. Walton and Declan G. Murphy 83. Population-Based Outcomes Following Treatment of Clinically-Localized Prostate CancerBlake Evans and Scott M. Gilbert 84. Management of Radiation Adverse EffectsSeth A. Strope 85. Management of Complications Following Minimally Invasive Prostate Cancer TherapyPaul Cathcart and Anthony J. Costello Section 8: Management of Emergencies and Palliative CareEditors: Steven A. Kaplan and Alexis E. Te 86. Prostate Cancer EmergenciesBethan C. Hickerton, Mohamed Abdulmajed, Manit Arya, and Iqbal S. Shergill 87. Management of Bone MetastasesKeen Hun Tai and Farshad Foroudi 88. Pain Relief in Metastatic CancerOdette Spruyt and Natasha Michael 89. The Psycho-Social Impact of Prostate CancerAddie Wooten and Heather Siddons 90. Nursing Issues in Prostate CancerHelen Crowe